The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Impairment expense | - | - | - | 2,690 |
| Bargain purchase gain | - | - | 2,418 | 1,693 |
| Net loss after taxes | - | - | - | -29,745 |
| Depreciation and amortization | - | 15 | -2,892 | 2,923 |
| Net cash used in discontinued operations | 0 | 0 | -8,523 | - |
| Interest expense on lease liability | 0 | -278 | - | 278 |
| Future tax recovery | 0 | 0 | - | - |
| Operating Activities Cash Flow Statement | 0 | - | - | - |
| Net loss | -6,381 | -8,614 | -8,639 | - |
| Acquisition costs | - | - | - | 3,341 |
| Depreciation and amortization | -61 | - | - | - |
| Gain on disposal of assets, net | - | - | - | 4,254 |
| Non-cash fixed assets adjustment | 73 | - | - | - |
| Share-based compensation | 0 | 961 | -1,245 | 4,451 |
| Debt discount amortization | 1,588 | 1,108 | 287 | - |
| Bad debt expense | -33 | -9 | - | - |
| Change in fair value of equity securities | -493 | - | - | - |
| Shares issued for settlement of accounts payable | - | - | - | -6,730 |
| Change in fair value of derivative liabilities | 592 | - | - | - |
| Income tax benefit, net | - | - | - | -678 |
| Noncash Income Expense | -8 | 0 | - | - |
| Loss on sale of cryptocurrency assets | - | - | 0 | -35 |
| Short-term investments, net | 3,005 | - | - | - |
| Accounts receivable, net | 716 | -897 | -2,437 | -2,969 |
| Inventories, net | 768 | -760 | 1,431 | -1,927 |
| Prepaid expenses and other assets | 37 | 587 | -9,190 | 10,019 |
| Accounts payable | -295 | -900 | -10,796 | 4,804 |
| Accrued liabilities | 217 | -85 | 1,181 | 70 |
| Loss on settlement of debt | 0 | -3,064 | -716 | - |
| Operating leases, net | - | - | - | -82 |
| Change in fair value of digital assets | -2,895 | -464 | - | - |
| Deferred revenue | - | - | - | 509 |
| Income tax provision | 2 | 4 | - | - |
| Cash (used in) provided by operating activities | -6,627 | -2,922 | 7,601 | -15,744 |
| Capital expenditures | - | - | - | 0 |
| Cash paid for acquisitions, net of assets acquired | 0 | 0 | - | - |
| Payments to acquire assets | - | - | - | 0 |
| Capital expenditures, net of disposals | 0 | 0 | - | - |
| Cash acquired in business combination | - | - | 0 | 5,940 |
| Purchase of intangible assets, net of disposals | 0 | 0 | - | - |
| Proceeds from sale of digital assets | 4,776 | - | 0 | 2,041 |
| Purchase of equity securities | 2,244 | - | - | - |
| Proceeds from sale of equities and option contracts (active trades) | 62,676 | - | - | - |
| Purchases of equities and option contracts (active trades) | 62,826 | - | - | - |
| Purchase of convertible note receivable | 1,407 | - | - | - |
| Purchase of digital assets | 8,008 | 8,460 | 0 | 2,076 |
| Proceeds from sale of assets | - | - | - | 7,375 |
| Cash (used in) provided by investing activities | -7,033 | -8,460 | -7,375 | 13,280 |
| Repayment of senior debt | 0 | 0 | - | - |
| Proceeds from share issuance | 0 | 0 | - | - |
| Proceeds from short-term borrowings | - | 0 | - | - |
| Proceeds of loans payable | 0 | 0 | - | - |
| Payment of principal portion of lease liabilities | 0 | 0 | - | 0 |
| Proceeds from short term borrowings | - | - | - | 859 |
| Repayment of short-term borrowings | - | - | - | 1,662 |
| Proceeds from long-term borrowings | - | - | - | 2,470 |
| Repayment of long-term borrowings | - | - | - | 7,614 |
| Proceeds from wintrust facility | - | - | 859 | - |
| Proceeds from private placements | - | - | - | 9,238 |
| Proceeds from pipe | - | - | 8,800 | - |
| Repayment of short-term borrowings | 0 | - | - | - |
| Payments on wintrust facility | - | - | 1,662 | - |
| Redemption of shares | 0 | - | 0 | 137 |
| Proceeds from short-term borrowings | - | - | 800 | - |
| Proceeds from issuance of common stock | 38,970 | 16,094 | - | - |
| Repayment on short-term borrowings | - | - | 800 | - |
| Proceeds from issuance of convertible preferred stock | 13,240 | - | - | - |
| Proceeds from issuance of convertible debt | - | - | 6,120 | - |
| Proceeds from issuance of preferred stock | - | 8,912 | - | - |
| Redemption of series a convertible preferred stock | 21,773 | - | - | - |
| Repayment of convertible debt | 0 | 1,623 | 1,655 | - |
| Cash paid for financing costs | 375 | 250 | 154 | - |
| Repurchase of common stock | 7 | - | - | - |
| Cash provided by (used in) financing activities | 21,143 | 23,133 | 9,017 | 3,154 |
| Net cash provided by continuing operations | 7,483 | 11,751 | 9,933 | - |
| Net increase (decrease) in cash and cash equivalents | 7,483 | 11,061 | - | 690 |
| Net increase (decrease) in cash | - | - | 1,410 | - |
| Effect of exchange rate changes on cash | - | - | -323 | 116 |
| Total cash and cash equivalents, beginning of period | 13,060 | 1,309 | 912 | 106 |
| Total cash and cash equivalents, end of period | 20,543 | 13,060 | 1,309 | 912 |
SRx Health Solutions, Inc. (SRXH)
SRx Health Solutions, Inc. (SRXH)